Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea

PHASE4CompletedINTERVENTIONAL

Enrollment

151

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Clostridium Difficile Infection

Interventions

DRUG

Rifaximin

Tablets

DRUG

Placebo

Tablets

Trial Locations (1)

Nottingham Clinical Trials Unit (NCTU), Queen's Medical Centre, Nottingham

All Listed Sponsors

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

University of Nottingham

OTHER

NCT01670149 - Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea | Biotech Hunter | Biotech Hunter